Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback